Article
Biochemistry & Molecular Biology
Giovanni Di Bonaventura, Veronica Lupetti, Simone De Fabritiis, Alessandra Piccirilli, Annamaria Porreca, Marta Di Nicola, Arianna Pompilio
Summary: This study evaluated the antibacterial and antivirulence activities of eight FDA-approved non-antibiotic drugs and their effects on biofilm formation. Ciclopirox and actinomycin D showed the best antibacterial activity and were most effective against preformed biofilms.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Microbiology
Giovanni Di Bonaventura, Veronica Lupetti, Fabio Verginelli, Sara Giancristofaro, Rosemary Barbieri, Giovanni Gherardi, Arianna Pompilio
Summary: This study evaluated the antibacterial, antibiofilm, and antivirulence activities of apramycin compared to tobramycin against P. aeruginosa in cystic fibrosis patients. Apramycin showed better efficacy than tobramycin, without cytotoxicity to bronchial epithelial CF cells.
FRONTIERS IN MICROBIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Marco Artini, Gianluca Vrenna, Marika Trecca, Vanessa Tuccio Guarna Assanti, Ersilia Vita Fiscarelli, Rosanna Papa, Laura Selan
Summary: Pseudomonas aeruginosa is a bacterium frequently involved in cystic fibrosis airway infections. It increases its virulence through biofilm, motility, toxin production, and invasion of host cells. The metalloprotease serratiopeptidase (SPEP) has been shown to impair the virulence-related properties of Gram-positive bacteria. In this study, the effects of SPEP on different physiological aspects related to the virulence of P. aeruginosa isolated from CF patients were investigated. The results showed that SPEP impaired attachment to inert surfaces and adhesion/invasion of eukaryotic cells. It also had strain-dependent effects on pyocyanin and pyoverdine production. Additionally, SPEP seemed to increase swarming motility and staphylolytic protease production. Further studies are needed to understand why different strains react differently to specific treatments.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Microbiology
Madeline Mei, Jacob Thomas, Stephen P. Diggle
Summary: The research revealed that heterogeneous populations of Pseudomonas aeruginosa exhibit varying susceptibility to R-pyocins, likely due to differences in the LPS core. Further studies suggest that there is heterogeneity in response to other types of LPS-binding antimicrobials as well.
Article
Immunology
Jiwar Al-Zawity, Faria Afzal, Aysha Awan, Daniela Nordhoff, Alexander Kleimann, Daniel Wesner, Tristan Montier, Tony Le Gall, Mareike Muller
Summary: This study investigates the influence of the steroid sex hormone estradiol (E-2) on biofilm formation of Pseudomonas aeruginosa in cystic fibrosis (CF) patients. The results show that E-2 treatment can increase the attached biofilm mass, remodel the biofilm ultrastructure, and potentially modulate the QS signaling in the biofilm.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2022)
Article
Microbiology
Marco Artini, Rosanna Papa, Filippo Sapienza, Mijat Bozovic, Gianluca Vrenna, Vanessa Tuccio Guarna Assanti, Manuela Sabatino, Stefania Garzoli, Ersilia Vita Fiscarelli, Rino Ragno, Laura Selan
Summary: The study evaluated the biofilm growth modulation exerted by 61 commercial essential oils on a selected number of P. aeruginosa strains isolated from CF patients. Additionally, machine learning techniques were used to identify the essential oil chemical components responsible for the positive or negative modulation of bacterial biofilm formation.
Article
Infectious Diseases
Giovanna Batoni, Elisa Catelli, Esinguel Kaya, Arianna Pompilio, Marta Bianchi, Emilia Ghelardi, Giovanni Di Bonaventura, Semih Esin, Giuseppantonio Maisetta
Summary: Therapy of lung infections caused by Pseudomonas aeruginosa in cystic fibrosis patients is challenging due to the presence of sticky mucus and antibiotic-tolerant biofilm. This study evaluates the growth of probiotic strains in an artificial sputum medium and their effects on planktonic and biofilm growth of clinical strains of P. aeruginosa. The results show that Lacticaseibacillus rhamnosus and Lactiplantibacillus plantarum can grow in the sputum medium and inhibit the growth of P. aeruginosa, including the pre-formed biofilm.
Review
Biochemistry & Molecular Biology
Isaac Martin, Valerie Waters, Hartmut Grasemann
Summary: The treatment of lung infection in cystic fibrosis is limited by the biofilm growth of pathogenic organisms. Interventions targeting bacteria, extracellular matrix components, and signaling pathways offer potential new therapeutic strategies to overcome current limitations.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Biochemistry & Molecular Biology
Marco Artini, Esther Imperlini, Francesco Buonocore, Michela Relucenti, Fernando Porcelli, Orlando Donfrancesco, Vanessa Tuccio Guarna Assanti, Ersilia Vita Fiscarelli, Rosanna Papa, Laura Selan
Summary: This study demonstrates the anti-biofilm and anti-virulence activity of KHS-Cnd against clinical strains of Pseudomonas aeruginosa. It impairs biofilm development and causes biofilm disaggregation, while also reducing adhesion to host cells and inhibiting invasion. The potential of KHS-Cnd as a therapeutic agent against P. aeruginosa is highlighted.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Chemistry, Medicinal
Marta Guerini, Giorgia Condro, Valeria Friuli, Lauretta Maggi, Paola Perugini
Summary: N-acetylcysteine is a powerful antioxidant and antidote for paracetamol overdose. It has also shown potential as a drug for diseases like cystic fibrosis, playing a role in reducing inflammation and restoring redox balance. Additionally, NAC has been found to prevent and eliminate biofilms caused by CF airway infections.
Review
Microbiology
Christina S. Thornton, Michael G. Surette
Summary: Cystic fibrosis is the most common and lethal genetic disease among the Caucasian population, leading to chronic airway inflammation and declining pulmonary function. Studies have shown a diverse community of anaerobic bacteria in CF patients' airways, potentially impacting disease progression through synergistic interaction with principal pathogens. Despite the understanding of this complex bacterial milieu, the specific roles of anaerobes in disease progression remain unclear.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Article
Microbiology
Xuerui Bao, Mona Bove, Tom Coenye
Summary: The high tolerance of Pseudomonas aeruginosa biofilms in respiratory tract infections in cystic fibrosis contributes to the failure of antibiotic therapy. This study identified carbon sources that could enhance the inhibiting and/or eradicating activity of tobramycin, ciprofloxacin, and ceftazidime against P. aeruginosa PAO1 biofilms. The mechanisms underlying the enhanced biofilm eradicating activity were strain-dependent.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Article
Infectious Diseases
Catalina Diaz-Rios, Marta Hernandez, David Abad, Laura Alvarez-Montes, Athanasia Varsaki, David Iturbe, Jorge Calvo, Alain A. Ocampo-Sosa
Summary: A study investigated the phenotypic and genotypic characteristics of multidrug-resistant Pseudomonas aeruginosa isolates collected from a cystic fibrosis patient, revealing different colony morphologies, pigmentation, and resistance genes. The findings suggest an adaptation of the clone to the cystic fibrosis lung environment through mutations affecting biofilm formation, quorum sensing, and antimicrobial resistance genes.
Review
Immunology
Veronica Roxana Flores-Vega, Silvia Yalid Vargas-Roldan, Jose Luis Lezana-Fernandez, Ricardo Lascurain, Jose Ignacio Santos-Preciado, Roberto Rosales-Reyes
Summary: Cystic fibrosis is a genetic disease caused by a mutation in the cftr gene, affecting chloride ion and water transport and leading to bacterial infections in the lungs. Autophagy plays a crucial role in pathogen clearance, but P. aeruginosa and B. cenocepacia have strategies to evade this pathway, resulting in chronic inflammatory immune responses.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Jonathan Chung, Shafinaz Eisha, Subin Park, Amanda J. Morris, Isaac Martin
Summary: In cystic fibrosis (CF), pulmonary infection with Pseudomonas aeruginosa is a major cause of morbidity and mortality. The biofilm mode of growth of P. aeruginosa, with its self-secreted exopolysaccharides (EPSs), provides physical protection against antibiotics and leads to phenotypic heterogeneity. Current antimicrobials are inadequate in eradicating P. aeruginosa infection, thus there is a need for new therapies. This review focuses on the investigation and exploitation of the three biofilm-associated EPSs as potential therapeutic targets for combating pulmonary infection with P. aeruginosa in CF.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)